For citations:
Sumarokov A.B., Buryachkovskaya L.I., Docenko Y.V., Kurochkin M.S., Lomakin N.V. Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients. Rational Pharmacotherapy in Cardiology. 2020;16(1):99-107. (In Russ.) https://doi.org/10.20996/1819-6446-2020-01-03
.jpg)
Email this article 